| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/29/1997 | CA2238028A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/28/1997 | EP0775746A2 Coccidiosis poultry vaccine |
| 05/28/1997 | EP0775743A2 Sustainable chick cell line infected with Marek's disease virus |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775495A1 Use of a disaccharide as stabilizer for liquid protein mixtures and liquid protein mixtures containing a disaccharide |
| 05/28/1997 | EP0775494A1 Peroral immunogen composition and process for producing the same |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 05/28/1997 | EP0775198A1 Molecular presenting system |
| 05/28/1997 | EP0775116A1 Carbamazepine hydrazides useful in immunoassays |
| 05/28/1997 | EP0774974A1 Novel vaccine adjuvant and vaccine |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0774964A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 05/28/1997 | EP0526511B1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | EP0455705B1 Receptor membranes and ionophore gating |
| 05/28/1997 | DE19543649A1 Tumour vaccine containing tumour cells loaded with peptide(s) that bind to MHC Class I |
| 05/28/1997 | DE19543554A1 Identifizierung von Antigenen aus post-infektiösen Nematoden zur Entwicklung neuer Anthelmintika und Vakzinen Identification of antigens from post-infective nematodes to develop new vaccines and anthelmintics |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | CN1150840A A method for detecting presence of mycobacterium species and kit and antibodies for use therein |
| 05/28/1997 | CN1150819A Vaccine against mumps containing jeryl-Lynn virus strain |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1034986C Immunogenic composite pharmaceutics and its preparation method |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633351 Targeting protein-diagnostic/therapeutic agent conjugates having Schiff base linkages |
| 05/27/1997 | US5633347 Treatment of small-cell lung carcinomas |
| 05/27/1997 | US5633234 Lysosomal targeting of immunogens |
| 05/27/1997 | US5633226 Water in oil emulsion with water solubility active ingredient, triglyceride or diester of propylene glycol, surfactant and additive capable of converting mixture to oil in water emulsion by addition of water |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633141 Assaying platelet factor 4 neutrophil agonists |
| 05/27/1997 | US5633139 Polypeptides |
| 05/27/1997 | US5632992 Process for the expression of herpes simplex virus type 1 glycoprotein E and method of use |
| 05/27/1997 | US5632989 Screening with a monoclonal antibodies |
| 05/27/1997 | US5632982 Cytotoxic enhancement of TNF with copper |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632968 Detection of cardiovascular lesions |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018475A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | WO1997018311A1 Polyvalent anti-dengue vaccine |
| 05/22/1997 | WO1997018309A1 E6 binding proteins |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | WO1997018225A1 Salmonella secreted proteins and uses thereof |
| 05/22/1997 | WO1997017993A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 05/22/1997 | WO1997005468A3 A confirmatory serodiagnostic assay for infectious diseases |
| 05/22/1997 | DE19542761A1 Use of complex of human immunoglobulin and histamine |
| 05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
| 05/22/1997 | CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | CA2237783A1 E6 binding proteins |
| 05/22/1997 | CA2237581A1 Salmonella secreted proteins and uses thereof |
| 05/22/1997 | CA2237398A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 05/22/1997 | CA2237299A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | CA2235334A1 Polyvalent anti-dengue vaccine |
| 05/22/1997 | CA2234661A1 Mimotopes and anti-mimotopes of human platelet glycoprotein ib/ix |
| 05/21/1997 | EP0774513A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 05/21/1997 | EP0774262A1 Pharmaceutical compositions comprising a neutralized virus and use thereof |
| 05/21/1997 | EP0774250A1 Use of a TNF alpha antagonist against skin redness of neurogenic origin |
| 05/21/1997 | EP0774002A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 05/21/1997 | EP0774000A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773957A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 05/21/1997 | EP0773951A1 Dinucleoside-5',5'-pyrophosphates |
| 05/21/1997 | EP0773787A1 HLA binding peptides and their uses |
| 05/21/1997 | EP0679187B1 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 05/21/1997 | EP0658195B1 Virus obtainable from human neuroblastoma cells |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1150388A Immunotherapeutic agent and its use |
| 05/21/1997 | CN1034976C Method for determining producing mucin antigen cell |
| 05/20/1997 | US5631407 Testing the efficacy of a vaccine to determine protection from infection by human picornavirus; genetic engineering |
| 05/20/1997 | US5631350 Anti-human influenza virus antibody |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631348 Protein sequence of the plant toxin gelonin |
| 05/20/1997 | US5631221 Pollenosis-inducing polypeptide, process for preparing the same, and uses thereof |
| 05/20/1997 | US5631154 Polypeptides, genetic engineering and assembly of defective viral particles |
| 05/20/1997 | US5631010 Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1 |
| 05/20/1997 | US5631009 Erythrocytes and reaction with antisera and antibodies |
| 05/20/1997 | US5630996 Two-step pretargeting methods using improved biotin-active agent conjugates |
| 05/20/1997 | US5630796 High speed delivery of dry drug particles |
| 05/15/1997 | WO1997017612A1 Prevention of sudden infant death |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017444A2 Novel sperm receptors |
| 05/15/1997 | WO1997017427A1 Novel process for the propagation of b. pertussis |
| 05/15/1997 | WO1997017372A1 Production of antibodies, and medical uses involving antibodies |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017082A1 A vaccine against toxoplasma gondii |
| 05/15/1997 | WO1997017063A1 Microencapsulated dna for vaccination and gene therapy |
| 05/15/1997 | WO1997011093A3 Parainfluenza virus glycoproteins and vaccines |
| 05/15/1997 | WO1997001640A3 Vaccines against hepatitis c |
| 05/15/1997 | DE19534763C1 FMR1-verwandtes Protein FMR1-related protein |
| 05/14/1997 | EP0773295A2 DNA-based vaccination of fish by immersion |
| 05/14/1997 | EP0773030A1 Method of purifying necrotoxin produced by bordetella and toxoid |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |